Comparison of Adalimumab Monotherapy and a Combination With Azathioprine for Patients With Crohn's Disease: A Prospective, Multicenter, Open-Labeled Clinical Trial (DIAMOND Study)

被引：1
|
作者：
Matsumoto, Takayuki
Motoya, Satoshi
Watanabe, Kenji
Hisamatsu, Tadakazu
Nakase, Hiroshi
Yoshimura, Naoki
Ishida, Tetsuya
Kato, Shingo
Nakagawa, Tomoo
Esaki, Motohiro
Nagahori, Masakazu
Matsui, Toshiyuki
Naito, Yuji
Kanai, Takanori
Suzuki, Yasuo
Nojima, Masanori
Watanabe, Mamoru
Hibi, Toshifumi
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)30697-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
854
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [31] Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial
    Ni, Zhaohui
    Zhang, Zhen
    Yu, Zanzhe
    Lu, Fuming
    Mei, Changlin
    Ding, Xiaoqiang
    Yuan, Weijie
    Zhang, Wei
    Jiang, Gengru
    Sun, Min
    He, Liqun
    Deng, Yueyi
    Pang, Huihua
    Qian, Jiaqi
    RENAL FAILURE, 2021, 43 (01) : 1214 - 1221
  • [32] Adalimumab monotherapy versus combination therapy with immunomodulators in patients with Crohn's disease: A systematic review and meta-analysis
    Kopylov, Uri
    Al-Taweel, Talal
    Yaghoobi, Mohammad
    Nauche, Benedicte
    Bitton, Alain
    Lakatos, Peter L.
    Ben-Horin, Shomron
    Afif, Waqqas
    Seidman, Ernest G.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (12): : 1632 - 1641
  • [33] COMPARISON OF ONE-YEAR OUTCOMES BETWEEN ADALIMUMAB AND INFLIXIMAB IN CHILDREN WITH LUMINAL CROHN'S DISEASE: A MULTICENTER PROSPECTIVE COHORT STUDY
    deBruyn, Jennifer C.
    Huynh, Hien Q.
    Griffiths, Anne M.
    Jacobson, Kevan
    Mack, David R.
    Deslandres, Colette
    El-Matary, Wael
    Otley, Anthony
    Lawrence, Sally
    Wine, Eytan
    Sherlock, Mary
    Critch, Jeffrey
    Jantchou, Prevost
    Rashid, Mohsin
    Carroll, Matthew
    Bax, Kevin
    Seidman, Ernest G.
    Benchimol, Eric I.
    Ricciuto, Amanda
    Church, Peter
    Walters, Thomas D.
    GASTROENTEROLOGY, 2022, 162 (07) : S236 - S236
  • [34] Clinical efficacy of treatment with Infliximab in a German multicenter, prospective, open-label trial in refractory Crohn's disease.
    Schreiber, S
    Kuehbacher, T
    Mascheretti, S
    Hommel, E
    Pohl, C
    Kruis, W
    Andus, T
    Lochs, H
    Fleig, W
    Thriene, W
    GASTROENTEROLOGY, 2000, 118 (04) : A568 - A568
  • [35] EXPERIENCE IN PERSONIFYING THE STANDARD TREATMENT OF PATIENTS WITH HEMOPHILIA A: RESULTS OF A MULTICENTER RUSSIAN OPEN-LABELED PROSPECTIVE STUDY EVALUATING THE USE OF HAEMOCTIN
    Zozulya, N. I.
    Plyushch, O. P.
    TERAPEVTICHESKII ARKHIV, 2010, 82 (04) : 56 - 61
  • [36] Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial
    Van Assche, Gert
    Vermeire, Severine
    Ballet, Vera
    Gabriels, Frederik
    Noman, Maja
    D'Haens, Geert
    Claessens, Christophe
    Humblet, Evelien
    Casteele, Niels Vande
    Gils, Ann
    Rutgeerts, Paul
    GUT, 2012, 61 (02) : 229 - 234
  • [37] Losartan/hydrochlorothiazide combination vs. high-dose losartan in patients with morning hypertension-a prospective, randomized, open-labeled, parallel-group, multicenter trial
    Ueda, Tamenobu
    Kai, Hisashi
    Imaizumi, Tsutomu
    HYPERTENSION RESEARCH, 2012, 35 (07) : 708 - 714
  • [38] Adalimumab vs Infliximab in Luminal Pediatric Crohn's Disease: Comparable Outcomes in a Prospective Multicenter Cohort Study
    debruyn, Jennifer C.
    Huynh, Hien Q.
    Griffiths, Anne M.
    Jacobson, Kevan
    Mack, David
    Deslandres, Colette
    El-Matary, Wael
    Otley, Anthony R.
    Church, Peter C.
    Lawrence, Sally
    Wine, Eytan
    Sherlock, Mary
    Critch, Jeffrey
    Benchimol, Eric I.
    Jantchou, Prevost
    Rashid, Mohsin
    Carroll, Matthew W.
    Bax, Kevin
    Ricciuto, Amanda
    Carman, Nicholas
    Walters, Thomas D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (03): : 565 - 575
  • [39] Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn's Disease: A Post Hoc Analysis of the PAILOT Randomized Controlled Trial
    Matar, Manar
    Shamir, Raanan
    Turner, Dan
    Broide, Efrat
    Weiss, Batia
    Ledder, Oren
    Guz-Mark, Anat
    Rinawi, Firas
    Cohen, Shlomi
    Topf-Olivestone, Chani
    Shaoul, Ron
    Yerushalmi, Baruch
    Ben-Horin, Shomron
    Assa, Amit
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (11) : 1627 - 1635
  • [40] Biomarkers for the efficacy of azathioprine/mercaptopurine in patients with Crohn's disease: a retrospective clinical study
    Yang, Ting
    Wang, Xueding
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 385 - 386
12345